Drug Information

Drug General Information
Drug ID
D0E8PR
Former ID
DIB014883
Drug Name
BAY1163877
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [524506]
Company
Bayer healthcare pharmaceuticals
Target and Pathway
Target(s) Fibroblast growth factor receptor Target Info Antagonist [549768]
References
Ref 524506ClinicalTrials.gov (NCT01976741) Phase I Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor. U.S. National Institutes of Health.
Ref 549768Preclinical profile of BAY 1163877 - a selective pan-FGFR inhibitor in phase 1 clinical trial. Cancer Research. 10/2014; 74(19 Supplement):1739-1739.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.